Skip to main content
SpringerLink
Log in

Variants in LTA, TNF, IL1B and IL10 genes associated with the clinical course of sepsis

  • Original Article
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

The aim of this study was to explore the association between some SNPs of the TNF, LTA, IL1B and IL10 genes with cytokine concentrations and clinical course in Colombian septic patients. We conducted a cross-sectional study to genotype 415 septic patients and 205 patients without sepsis for the SNPs −308(G/A) rs1800629 of TNF; +252 (G/A) rs909253 of LTA; −511(A/G) rs16944 and +3953(C/T) rs1143634 of IL1B; and −1082(A/G) rs1800896, −819(C/T) rs1800871 and −592(C/A) rs1800872 of IL10. The association of theses SNPs with the following parameters was evaluated: (1) the presence of sepsis; (2) severity and clinical outcomes; (3) APACHE II and SOFA scores; and (4) procalcitonin, C-reactive protein, tumor necrosis factor, lymphotoxin alpha, interleukin 1 beta and interleukin 10 plasma concentrations. We found an association between the SNP LTA +252 with the development of sepsis [OR 1.29 (1.00–1.68)]; the SNP IL10 −1082 with sepsis severity [OR 0.53 (0.29–0.97)]; the TNF −308 with mortality [OR 0.33 (0.12–0.95)]; and the IL10 −592 and IL10 −1082 with admission to the intensive care unit (ICU) [OR 3.36 (1.57–7.18)] and [OR 0.18 (0.04–0.86)], respectively. None of the SNPs were associated with cytokine levels, procalcitonin and C-reactive protein serum concentrations, nor with APACHE II and SOFA scores. Our results suggest that these genetic variants play an important role in the development of sepsis and its clinical course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5:4–11. doi:10.4161/viru.27372.

    Article  PubMed  Google Scholar 

  2. Rodríguez F, Barrera L, De La Rosa G, et al. The epidemiology of sepsis in Colombia: a prospective multicenter cohort study in ten university hospitals. Crit Care Med. 2011;39:1675–82. doi:10.1097/CCM.0b013e318218a35e.

    Article  PubMed  Google Scholar 

  3. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530–8. doi:10.1007/s00134-003-1662-x.

    Article  PubMed  Google Scholar 

  4. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:762–74. doi:10.1001/jama.2016.0288.

    Article  CAS  PubMed  Google Scholar 

  5. Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence. 2014;5:36–44. doi:10.4161/viru.25436.

    Article  PubMed  Google Scholar 

  6. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev. 2013;93:1247–88. doi:10.1152/physrev.00037.2012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cui L, Gao Y, Xie Y, et al. An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis. Crit Care. 2015;19:796. doi:10.1186/s13054-015-0796-x.

    Article  Google Scholar 

  8. Wang TS, Deng JC. Molecular and cellular aspects of sepsis-induced immunosuppression. J Mol Med (Berl). 2008;86:495–506. doi:10.1007/s00109-007-0300-4.

    Article  CAS  PubMed  Google Scholar 

  9. Papathanassoglou EDE, Giannakopoulou MD, Bozas E. Genomic variations and susceptibility to sepsis. AACN Adv Crit Care. 2009;17:394–422.

    Google Scholar 

  10. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med. 1996;24:163–72.

    Article  CAS  PubMed  Google Scholar 

  11. Sugitharini V, Prema A, Berla Thangam E. Inflammatory mediators of systemic inflammation in neonatal sepsis. Inflamm Res. 2013;62:1025–34. doi:10.1007/s00011-013-0661-9.

    Article  CAS  PubMed  Google Scholar 

  12. Damas P, Canivet JL, de Groote D, et al. Sepsis and serum cytokine concentrations. Crit Care Med. 1997;25:405–12.

    Article  CAS  PubMed  Google Scholar 

  13. Kumar AT, Sudhir U, Punith K, et al. Cytokine profile in elderly patients with sepsis. Indian J Crit Care Med. 2009;13:74–8. doi:10.4103/0972-5229.56052.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Oberholzer A, Souza SM, Tschoeke SK, et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock. 2005;23:488–93.

    CAS  PubMed  Google Scholar 

  15. De La Rosa GD, Valencia ML, Arango CM, et al. Toward an operative diagnosis in sepsis: a latent class approach. BMC Infect Dis. 2008;8:18. doi:10.1186/1471-2334-8-18.

    Article  Google Scholar 

  16. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75. doi:10.1086/519795.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005;76:887–93. doi:10.1086/429864.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5. doi:10.1093/bioinformatics/bth457.

    Article  CAS  PubMed  Google Scholar 

  19. Davis SM, Clark EAS, Nelson LT, Silver RM. The association of innate immune response gene polymorphisms and puerperal group A streptococcal sepsis. Am J Obstet Gynecol. 2010;202:308-e1–8. doi:10.1016/j.ajog.2010.01.006.

    Article  Google Scholar 

  20. Kietthubthew S, Wickliffe J, Sriplung H, et al. Association of polymorphisms in proinflammatory cytokine genes with the development of oral cancer in Southern Thailand. Int J Hyg Environ Health. 2010;213:146–52. doi:10.1016/j.ijheh.2010.01.002.

    Article  CAS  PubMed  Google Scholar 

  21. Paskulin DD, Fallavena PR, Paludo FJ, et al. TNF −308G > a promoter polymorphism (rs1800629) and outcome from critical illness. Braz J Infect Dis. 2011;15:231–8.

    Article  PubMed  Google Scholar 

  22. Schaaf BM, Boehmke F, Esnaashari H, et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med. 2003;168:476–80. doi:10.1164/rccm.200210-1164OC.

    Article  PubMed  Google Scholar 

  23. Surbatovic M, Grujic K, Cikota B, et al. Polymorphisms of genes encoding tumor necrosis factor-α, interleukin-10, cluster of differentiation-14 and interleukin-1ra in critically ill patients. J Crit Care. 2010;25(542):e1–8. doi:10.1016/j.jcrc.2009.12.003.

    Google Scholar 

  24. Teuffel O, Ethier M-C, Beyene J, Sung L. Association between tumor necrosis factor-α promoter −308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis. Crit Care Med. 2010;38:276–82. doi:10.1097/CCM.0b013e3181b42af0.

    Article  CAS  PubMed  Google Scholar 

  25. Zeng L, Gu W, Chen K, et al. Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. Crit Care. 2009;13:R188. doi:10.1186/cc8182.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Zidan HE, Elbehedy RM, Azab SF. IL6-174 G/C gene polymorphism and its relation to serum IL6 in Egyptian children with community-acquired pneumonia. Cytokine. 2014;67:60–4. doi:10.1016/j.cyto.2014.02.013.

    Article  CAS  PubMed  Google Scholar 

  27. Shao Y, Li J, Cai Y, et al. The functional polymorphisms of miR-146a are associated with susceptibility to severe sepsis in the Chinese population. Mediat Inflamm. 2014;. doi:10.1155/2014/916202.

    Google Scholar 

  28. Ramakrishna K, Pugazhendhi S, Kabeerdoss J, Peter JV. Association between heat shock protein 70 gene polymorphisms and clinical outcomes in intensive care unit patients with sepsis. Indian J Crit Care Med. 2014;18:205–11. doi:10.4103/0972-5229.130571.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wang D, Zhong X, Huang D, et al. Functional polymorphisms of interferon-γ affect pneumonia-induced sepsis. PLoS One. 2014;9:e87049. doi:10.1371/journal.pone.0087049.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Gracia F, Armien B, Simpson SQ, et al. Convalescent pulmonary dysfunction following hantavirus pulmonary syndrome in Panama and the United States. Lung. 2010;188:387–91. doi:10.1007/s00408-010-9245-4.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Cardona-Castro N, Sánchez-Jiménez M, Rojas W, Bedoya-Berrío G. IL-10 gene promoter polymorphisms and leprosy in a Colombian population sample. Biomédica. 2012;32:71–6. doi:10.1590/S0120-41572012000100009.

    PubMed  Google Scholar 

  32. Guarnizo-Zuccardi P, Lopez Y, Giraldo M, et al. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens. 2007;70:376–82. doi:10.1111/j.1399-0039.2007.00917.x.

    Article  CAS  PubMed  Google Scholar 

  33. Romero-Sánchez C, Londoño J, Delgado G, et al. Association of tumor necrosis factor α-308 promoter polymorphism with spondyloarthritides patients in Colombia. Rheumatol Int. 2012;32:2195–7. doi:10.1007/s00296-011-1883-1.

    Article  PubMed  Google Scholar 

  34. Camargo JF, Correa PA, Castiblanco J, Anaya J-M. Interleukin-1β polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun. 2004;5:609–14. doi:10.1038/sj.gene.6364133.

    Article  CAS  PubMed  Google Scholar 

  35. Watanabe E, Buchman TG, Hirasawa H, Zehnbauer BA. Association between lymphotoxin-α (tumor necrosis factor-β) intron polymorphism and predisposition to severe sepsis is modified by gender and age. Crit Care Med. 2010;38:181–93. doi:10.1097/CCM.0b013e3181bc805d.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Tiancha H, Huiqin W, Jiyong J, et al. Association between lymphotoxin-α intron +252 polymorphism and sepsis: a meta-analysis. Scand J Infect Dis. 2011;43:436–47. doi:10.3109/00365548.2011.562528.

    Article  PubMed  Google Scholar 

  37. Shu Q, Fang X, Chen Q, Stuber F. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin Med J (Engl). 2003;116:1756–9.

    CAS  PubMed  Google Scholar 

  38. Stanilova SA, Miteva LD, Karakolev ZT, Stefanov CS. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med. 2006;32:260–6. doi:10.1007/s00134-005-0022-4.

    Article  CAS  PubMed  Google Scholar 

  39. Gomez HG, Gonzalez SM, Londoño JM, et al. Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*. Crit Care Med. 2014;42:771–80. doi:10.1097/CCM.0000000000000100.

    Article  CAS  PubMed  Google Scholar 

  40. de Oliveira Paludo FJ, Picanço JB, de Fallavena PRV, et al. Higher frequency of septic shock in septic patients with the 47C allele (rs4880) of the SOD2 gene. Gene. 2013;517:106–11. doi:10.1016/j.gene.2012.10.078.

    Article  Google Scholar 

Download references

Acknowledgments

We thank COLCIENCIAS for its financial support (Grant 111551928730) and the program “Estrategia de Sostenibilidad 2014–2015 de la Universidad de Antioquia.” Mayra Alejandra Diosa helped in DNA isolation, and David Arcila helped in the English correction. The authors wish to thank Anne-Lise Haenni for her constructive comments.

Author information

Authors and Affiliations

  1. Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia

    Carolina Montoya-Ruiz, Maria T. Rugeles & Paula A. Velilla

  2. Grupo Académico de Epidemiologia Clínica, Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia

    Fabián A. Jaimes

  3. Departamento de Medicina Interna, Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia

    Fabián A. Jaimes

  4. Unidad de Investigaciones, Hospital Pablo Tobón Uribe Medellín, Calle 78B No. 69-240, Medellín, Colombia

    Fabián A. Jaimes

  5. Escuela de Microbiología, Grupo Inmunodeficiencias Primarias-Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia

    Juan Álvaro López

  6. Grupo Genética Molecular, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia

    Gabriel Bedoya

  7. School of Medicine, University of Antioquia, Carrera 53 No. 61-30 Lab. 532, Sede de Investigación Universitaria – SIU, Medellín, Colombia

    Paula A. Velilla

Authors
  1. Carolina Montoya-Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabián A. Jaimes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria T. Rugeles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Juan Álvaro López
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gabriel Bedoya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paula A. Velilla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paula A. Velilla.

Ethics declarations

Conflict of interest

All authors declare that they do not have a financial relationship with the organization that sponsored the research and have no conflict of interest.

Ethical approval

“All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or of the National Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.”

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 29 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Montoya-Ruiz, C., Jaimes, F.A., Rugeles, M.T. et al. Variants in LTA, TNF, IL1B and IL10 genes associated with the clinical course of sepsis. Immunol Res 64, 1168–1178 (2016). https://doi.org/10.1007/s12026-016-8860-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-016-8860-4

Keywords

Search

Navigation